These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 11094569)

  • 21. Dose-dependent olanzapine-associated leukopenia: three case reports.
    Kodesh A; Finkel B; Lerner AG; Kretzmer G; Sigal M
    Int Clin Psychopharmacol; 2001 Mar; 16(2):117-9. PubMed ID: 11236070
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Olanzapine-induced neutropenia after clozapine-induced neutropenia.
    Benedetti F; Cavallaro R; Smeraldi E
    Lancet; 1999 Aug; 354(9178):567. PubMed ID: 10470706
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Misdiagnosis of schizophrenia for a patient with epilepsy.
    Swartz CM
    Psychiatr Serv; 2001 Jan; 52(1):109. PubMed ID: 11141543
    [No Abstract]   [Full Text] [Related]  

  • 24. Olanzapine and haloperidol: potential for neutropenia?
    Abdullah N; Voronovitch L; Taylor S; Lippmann S
    Psychosomatics; 2003; 44(1):83-4. PubMed ID: 12515844
    [No Abstract]   [Full Text] [Related]  

  • 25. Neuroleptic malignant syndrome associated with olanzapine therapy: a case report.
    Stanfield SC; Privette T
    J Emerg Med; 2000 Nov; 19(4):355-7. PubMed ID: 11074330
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Two cases of olanzapine-induced reversible neutropenia.
    Steinwachs A; Grohmann R; Pedrosa F; Rüther E; Schwerdtner I
    Pharmacopsychiatry; 1999 Jul; 32(4):154-6. PubMed ID: 10505486
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A case of leukopenia in treatment with risperidone in an adolescent].
    Etain B; Roubaud L; Le Heuzey MF; Mouren Simeoni MC
    Encephale; 2000; 26(5):81-4. PubMed ID: 11192809
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Olanzapine-induced neutropenia.
    Gajwani P; Tesar GE
    Psychosomatics; 2000; 41(2):150-1. PubMed ID: 10749954
    [No Abstract]   [Full Text] [Related]  

  • 29. Influence of fluoxetine on olanzapine pharmacokinetics.
    Gossen D; de Suray JM; Vandenhende F; Onkelinx C; Gangji D
    AAPS PharmSci; 2002; 4(2):E11. PubMed ID: 12102620
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diabetic ketoacidosis associated with olanzapine in an adolescent patient.
    Selva KA; Scott SM
    J Pediatr; 2001 Jun; 138(6):936-8. PubMed ID: 11391346
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Olanzapine augmentation of fluoxetine in the treatment of refractory obsessive-compulsive disorder.
    Potenza MN; Wasylink S; Longhurst JG; Epperson CN; McDougle CJ
    J Clin Psychopharmacol; 1998 Oct; 18(5):423-4. PubMed ID: 9790164
    [No Abstract]   [Full Text] [Related]  

  • 32. Olanzapine and weight gain.
    Karagianis J
    Can J Psychiatry; 2000 Jun; 45(5):493. PubMed ID: 10900535
    [No Abstract]   [Full Text] [Related]  

  • 33. [Olanzapine in the first episode of schizophrenia in young adults].
    Dabkowska M
    Psychiatr Pol; 2002; 36(6 Suppl):235-41. PubMed ID: 12647444
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Neuroleptic malignant syndrome in a patient treated with olanzapine].
    Horni G; Meirik K; Lund MB
    Tidsskr Nor Laegeforen; 2003 Oct; 123(20):2867-9. PubMed ID: 14600711
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Olanzapine (Zyprexa)].
    Sahebjam M; Serra E
    Presse Med; 2000 Dec; 29(38):2106-8. PubMed ID: 11147054
    [No Abstract]   [Full Text] [Related]  

  • 36. 5-HT2A receptor promoter polymorphism, -1438G/A and negative symptom response to olanzapine in schizophrenia.
    Ellingrod VL; Lund BC; Miller D; Fleming F; Perry P; Holman TL; Bever-Stille K
    Psychopharmacol Bull; 2003; 37(2):109-12. PubMed ID: 14566219
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Safety and efficacy of olanzapine versus perphenazine in patients with schizophrenia: results of multicenter, 18-week, double-blind clinical trial].
    Jarema M; Olajossy M; Chrzanowski W; Araszkiewicz A; Landowski J; Rybakowski J; Bilikiewicz A; Bomba J; Debowska G
    Psychiatr Pol; 2003; 37(4):641-55. PubMed ID: 14560493
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Olanzapine and hypoglycemic coma in a frail elderly woman. A case report.
    Landi F; Cesari M; Zuccalà C; Barillaro C; Cocchi A
    Pharmacopsychiatry; 2003 Jul; 36(4):165-6. PubMed ID: 12971357
    [No Abstract]   [Full Text] [Related]  

  • 39. Remission of tardive dyskinesia after changing from flupenthixol to olanzapine.
    Haberfellner EM
    Eur Psychiatry; 2000 Aug; 15(5):338-9. PubMed ID: 10954879
    [No Abstract]   [Full Text] [Related]  

  • 40. Olanzapine-induced weight gain in patients with first-episode schizophrenia: a double-blind, placebo-controlled study of fluoxetine addition.
    Poyurovsky M; Pashinian A; Gil-Ad I; Maayan R; Schneidman M; Fuchs C; Weizman A
    Am J Psychiatry; 2002 Jun; 159(6):1058-60. PubMed ID: 12042201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.